Literature DB >> 21304190

Multidrug-resistant Enterobacteriaceae including metallo-β-lactamase producers are predominant pathogens of healthcare-associated infections in an Indian teaching hospital.

J B Sarma1, P K Bhattacharya, D Kalita, M Rajbangshi.   

Abstract

PURPOSE: A study was carried out in an Indian teaching hospital in 2009 to detect the rate of surgical site infections (SSI) and peripheral vascular access site infections.
MATERIALS AND METHODS: The study was a point-prevalence study involving over 300 patients. The presence of infection was determined according to the CDC criteria. Swabs were taken from the infected sites and identification and sensitivity were carried out using VITEK® 2 automated system. Characterisation of β-lactamase was carried out at ARRML, Colindale, London.
RESULTS: The rate of SSI was 15% for the clean and clean-contaminated categories while that for the dirty contaminated category was 85% (NNIS risk index 0). Cultures yielded definite or probable pathogens from 64% (9/14) of the patients with SSI. In 1/3 rd of the cultures, Staphylococcus aureus was grown and the rest had Enterobacteriaceae, either extended-spectrum β-lactamase (ESBL) producers or Amp-C hyperproducers and, alarmingly, three isolates were positive for newly recognised New Delhi metallo-β-lactamase-1 (NDM-1). In medicine, 87% (n = 99) of the patients had a peripheral IV access device, 55% developed associated phlebitis/infection and, in seven, probable pathogens were isolated (Candida species and Escherichia coli producing ESBL and NDM-1, respectively, Staphylococcus aureus and Enterococcus faecium). All ESBL and metallo-β-lactamase producers were resistant to multiple classes of antimicrobials, the latter being sensitive only to colistin and tigecycline. The study also found that all post-operative patients were on antibiotics, 92% on IV [213 defined daily doses (DDD)/100 post-op patients] limited mainly to the third-generation cephalosporins (26%) and aminoglycosides (24%) and imidazole derivatives (30%). In medicine, 83% (n = 82) were on IV antibiotics (123 DDD/100 bed-days), limited mainly to the third-generation cephalosporins (74%).
CONCLUSION: Indiscriminate use of antibiotics is a major problem predisposing patients to harm by multi-resistant pathogens. Carbapenems were in little use in this hospital, but the selection pressure exerted by cephalosporins and other unrelated classes was sufficient to select NDM-1-producing strains due to co-selection, suggesting a role of single plasmid carrying resistance genes to multiple classes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21304190     DOI: 10.4103/0255-0857.76519

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  8 in total

1.  The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them.

Authors:  Bhaskar Thakuria; Kingshuk Lahon
Journal:  J Clin Diagn Res       Date:  2013-06-01

2.  Structure of apo- and monometalated forms of NDM-1--a highly potent carbapenem-hydrolyzing metallo-β-lactamase.

Authors:  Youngchang Kim; Christine Tesar; Joseph Mire; Robert Jedrzejczak; Andrew Binkowski; Gyorgy Babnigg; James Sacchettini; Andrzej Joachimiak
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

3.  Antibiotic susceptibility pattern of Enterobacteriaceae and non-fermenter Gram-negative clinical isolates of microbial resource orchid.

Authors:  Periasamy Hariharan; Thirunavukkarasu Bharani; Jonathan Sampath Franklyne; Prithwijit Biswas; Shakti S Solanki; Maneesh Paul-Satyaseela
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

4.  New Delhi metallo-β-lactamase - type carbapenemases producing Escherichia coli isolates from hospitalized patients: A pilot study.

Authors:  Shyam Sunder Grover; Ananya Doda; Nupur Gupta; Inderjeet Gandhoke; Jyoti Batra; Charoo Hans; Shashi Khare
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

5.  Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples.

Authors:  Goutam Chowdhury; Gururaja Perumal Pazhani; Anirban Sarkar; Krishnan Rajendran; Asish K Mukhopadhyay; Mihir K Bhattacharya; Amit Ghosh; Thandavarayan Ramamurthy
Journal:  Emerg Infect Dis       Date:  2016-10       Impact factor: 6.883

6.  Molecular Characterization of Extended Spectrum β-lactamase and Carbapenemase Producing Klebsiella pneumoniae from a Tertiary Care Hospital.

Authors:  Beena Hosdurg Bhaskar; Shalini Shenoy Mulki; Sangeetha Joshi; Ranjeeta Adhikary; Bhavana Malavalli Venkatesh
Journal:  Indian J Crit Care Med       Date:  2019-02

7.  Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae: A Multi-Centric Study Across Karnataka.

Authors:  Sridhar Pn Rao; Prasad Subba Rama; Vishwanath Gurushanthappa; Radhakrishna Manipura; Krishna Srinivasan
Journal:  J Lab Physicians       Date:  2014-01

8.  Molecular characterization and in silico analysis of naturally occurring TEM beta-lactamase variants among pathogenic Enterobacteriaceae infecting Indian patients.

Authors:  Lena Dhara; Anusri Tripathi; Arijit Pal
Journal:  Biomed Res Int       Date:  2013-10-28       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.